Regeneron Pharmaceuticals (REGN) P/E (2010 - 2026)
Regeneron Pharmaceuticals (REGN) P/E from Jun 30, 2010 to Jul 21, 2026. The TTM Regeneron Pharmaceuticals (REGN) P/E is 16.11. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Regeneron Pharmaceuticals (REGN)
| Year | P/E | Change |
|---|---|---|
| 2026 | 16.11 | -1.23% |
| 2025 | 16.31 | -4.20% |
| 2024 | 17.03 | -25.40% |
| 2023 | 22.83 | +41.39% |
| 2022 | 16.14 | +62.20% |
| 2021 | 9.95 | -42.35% |
| 2020 | 17.27 | -18.93% |
| 2019 | 21.30 | +6.65% |
| 2018 | 19.97 | -35.30% |
| 2017 | 30.87 | -32.51% |
| 2016 | 45.74 | -53.98% |
| 2015 | 99.39 | -7.55% |
| 2014 | 107.50 | +110.19% |
| 2013 | 51.14 | -98.50% |
| 2012 | 3.41K | -12694.38% |
| 2011 | -27.08 | -25.00% |
| 2010 | -36.11 | N/A |
Comparison Regeneron Pharmaceuticals (REGN) P/E with competitors
Regeneron Pharmaceuticals (REGN) P/E is 16.11.